NASHVILLE, Tenn., (BUSINESS WIRE) -- Harrow Health, Inc. /zigman2/quotes/206805265/composite HROW -3.18% , an ophthalmic-focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in two upcoming virtual investor conferences.
Harrow Health will participate in the H.C. Wainwright Ophthalmology Virtual Conference to be held August 17, 2021. The Company’s pre-recorded presentation will be available via a link on the investor relations section of its website, harrowinc.com , beginning at 7:00 a.m. ET on Tuesday, August 17, 2021, and will remain archived there for approximately 90 days. Harrow Health’s management team will be participating in one‘on-one meetings during the conference. Interested investors can request meetings exclusively via H.C. Wainwright.
The Company will also be attending Lake Street Capital Market’s 5 [th] Annual Best Ideas Growth Conference (BIG5) on September 15, 2021. Management will be available throughout the day for one-on-one meetings with investors to provide an update on the Company’s business. Investors should contact their Lake Street representative to arrange a meeting or request an invitation.
About Harrow Health
Harrow Health, Inc. /zigman2/quotes/206805265/composite HROW -3.18% is an ophthalmic-focused healthcare company. The Company owns and operates ImprimisRx, one of the nation’s leading ophthalmology-focused pharmaceutical businesses, and Visionology, a direct-to-consumer eye care subsidiary focused on chronic eye disease. Harrow Health also holds non-controlling equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals, all of which started as Harrow Health subsidiaries, and owns royalty rights in four clinical-stage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210812005137/en/
SOURCE: Harrow Health, Inc.
Director of Communications and Investor Relations
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright Business Wire 2021